Researchers identified three distinct brain “biotypes” of ADHD, each with its own chemical signature—offering new clues about why treatment can feel like trial and error.
Collegium Pharmaceutical has tapped an appropriately glitzy star as the face of a new campaign spotlighting the bright side of life with attention-deficit/hyperactivity disorder (ADHD). | Collegium ...
Careful assessment of symptom patterns allows treatment strategies to be aligned with the patient’s specific challenges ...
A recent survey highlights variation in the training credentials and experience across the burgeoning industry, which is mostly unregulated and unlicensed ...
The hyperactivity disorder, usually referred to as ADHD, is an independent risk factor for several common and serious mental health issues, finds research published in the open access journal BMJ ...
While the U.S. Drug Enforcement Administration increased the production limit of stimulant drugs used to treat ADHD, there's still a high demand.
Sixteen Bay of Plenty GPs who are interested in providing attention deficit hyperactivity disorder services are upskilling in ...
Opinion
There Is No Over- or Under-diagnosis of ADHD or Autism, Just a Confused Cacophony of Opinions
The public narrative on ADHD, autism, and neurodivergence is infused with scientism—faith-based claims masquerading as scientific ones.
Autism and attention deficit hyperactivity disorder (ADHD) are fuelling a surge in employment tribunal cases amid a rapid rise in diagnoses across the country.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results